Publications by authors named "Mark Wininger"

Claim this Profile
R
Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone.
Juthika Kundu, Hoa T Le, Michael Logan, Darren Hockman, Abdolamir Landi, Mark Wininger

J Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
John L M Law, Michael Logan, Jason Wong, Juthika Kundu, Darren Hockman, Mark Wininger

J Virol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa.
Carlo Zambonelli, Antu K Dey, Susan Hilt, Samuel Stephenson, Eden P Go, Mark Wininger

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.
Yinling Lin, Taewoo Kwon, John Polo, Yi-Fei Zhu, Stephen Coates, Mark Wininger

J Virol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.
Zania Stamataki, Stephen Coates, Matthew J Evans, Mark Wininger, Kevin Crawford

Vaccine· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
Derek T O'Hagan, Manmohan Singh, Christine Dong, Mildred Ugozzoli, Kim Berger, Mark Wininger

Vaccine· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus.
Indresh K Srivastava, Leonidas Stamatatos, Harold Legg, Elaine Kan, Anne Fong, Mark Wininger

J Virol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis